Skip to main content

10X Capital Venture Acquisition Corp. III

VCXBDelisted Jul 26, 2024
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001848948

10X Capital Venture Acquisition Corp. III was delisted on Jul 26, 2024; its insiders filed their last Form 4 on Mar 11, 2022; 11 institutions reported holding it in 13F filings for Q2 2024, worth $21.4M in total; no superinvestor held it.

Q1 2024 vs. Q4 2023

How the institutions holding 10X Capital Venture Acquisition Corp. III changed between Q4 2023 and Q1 2024.

All holders in Q1 2024All holders in Q4 2023

13F holders of VCXB: Q4 2023 compared with Q1 2024
MeasureQ4 2023Q1 2024Change
Holders912+3
Shares2.01M1.95M−63.9K (−3.2%)
Value$21.6M$21.0M−$569.6K (−2.6%)

New holders (5)

Institutions that held 10X Capital Venture Acquisition Corp. III at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to VCXB in Q1 2024
InstitutionSharesValue% of portfolio
Berkley W R Corp198,960$2.14M0.13%
Flow State Investments, L.P.100,001$1.08M0.32%
K2 Principal Fund, L.P.95,380$1.03M0.25%
Wolverine Asset Management LLC91,230$983.5K0.02%
Crystalline Management Inc.87,500$943.3K1.23%

Sold out (2)

Institutions that held 10X Capital Venture Acquisition Corp. III at the end of Q4 2023 and filed for Q1 2024 without it.

Institutions that sold out of VCXB in Q1 2024
InstitutionShares, Q4 2023Value, Q4 2023
Kim, LLC400,000$4.29M
Mizuho Securities USA LLC187,500$1.99M